Literature DB >> 9245643

Role of leukocytes in diabetic microcirculatory disturbances.

K Miyamoto1, Y Ogura, S Kenmochi, Y Honda.   

Abstract

Various rheological abnormalities of the blood have been widely reported in diabetes. However, it remains unclear which one affects blood flow at the level of microcirculation, an important site in the pathogenesis of diabetic microangiopathy. To differentiate which blood component leads to microcirculatory disturbances in diabetes, we studied the hemorheological properties of diabetic patients using an array flow analyzer that has microchannels simulating capillaries. Venous blood was collected from 19 diabetic patients and 24 control subjects. Three blood samples were prepared: plasma alone, erythrocyte suspension (ES) at 10% hematocrit (Ht), and erythrocyte and leukocyte suspension (ELS) having leukocyte counts of 1000/microl at 10% Ht. These samples were forced to flow through microchannels (equivalent diameter 6 micron, equivalent length 30 micron, 2600 in parallel) by applying a pressure difference of 20 cm H2O. Transit times for 100 microl of samples were measured, and the flow behavior of cells through the microchannels was recorded with a video-microscope. The transit time of ELS was 52.5 +/- 6.2 sec (mean +/- SD) in the diabetic group and 47.7 +/- 3.3 sec in the control group; there was significant prolongation in the transit time of diabetic ELS (P = 0.005), whereas the transit times of plasma alone and ES showed no significant differences between control and diabetic groups. Leukocytes were occasionally observed to plug the microchannels during the measurements of ELS from some diabetic patients. Our results imply that reduced deformability of leukocytes in diabetes may contribute to flow disturbances in the microcirculation. Leukocytes could play a potential role in the pathogenesis of diabetic microangiopathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9245643     DOI: 10.1006/mvre.1997.2018

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  7 in total

1.  The pathogenesis of diabetic retinopathy.

Authors:  M R Stanford
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

2.  Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats.

Authors:  Yan-Ling Wang; Kang Wang; Shu-Jing Yu; Qian Li; Na Li; Peng-Yao Lin; Ming-Ming Li; Jian-You Guo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-31       Impact factor: 3.117

3.  Altered rheology of lymphocytes in the diabetic mouse.

Authors:  C M Perrault; E J Bray; N Didier; C K Ozaki; R Tran-Son-Tay
Journal:  Diabetologia       Date:  2004-10-23       Impact factor: 10.122

4.  Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.

Authors:  Shinsuke Miyahara; Junichi Kiryu; Kenji Yamashiro; Kazuaki Miyamoto; Fumitaka Hirose; Hiroshi Tamura; Hideto Katsuta; Kazuaki Nishijima; Akitaka Tsujikawa; Yoshihito Honda
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

5.  Vascular leucocyte adhesion molecules unaltered in the human retina in diabetes.

Authors:  J M Hughes; A Brink; A N Witmer; M Hanraads-de Riemer; I Klaassen; R O Schlingemann
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

6.  Red blood cell membrane mechanical fluctuations in non-proliferative and proliferate diabetic retinopathy.

Authors:  Michaella Goldstein; Igal Leibovitch; Shlomo Levin; Yair Alster; Anat Loewenstein; Galina Malkin; Rafi Korenstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-04       Impact factor: 3.117

7.  Increased 8-hydroxy-2'-deoxyguanosine in leukocyte DNA from patients with type 2 diabetes and microangiopathy.

Authors:  Xiaozhen Ye; Rong Jiang; Qianqian Zhang; Ruifeng Wang; Cuihua Yang; Jian Ma; Hong Du
Journal:  J Int Med Res       Date:  2016-03-23       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.